Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories

Page 2

Omeicos performs series C operation
SMS Group has backed a $19.5m series C for Omeicos Therapeutics to enable the Helmholtz spinout to advance its treatment for atrial fibrillation into a phase 2 trial.
Galecto collects $90m in series C
Bristol Myers-Squibb, Merck Group and Novo all took part in a $90m series C round for Galecto Biotech, which is commercialising research from Lund and Edinburgh universities.
Hard Yaka swings behind Yoyo Wallet for $30m
Hard Yaka has supplied $30m in funding to IP Group’s portfolio company Yoyo Wallet as part of a strategic partnership.
Investors pump $20m into Gauss
Stanford-StartX Fund's portfolio company Gauss Surgical has received series C funding from SoftBank and eight healthcare providers.
Rgenix generates $40m series C
The Rockefeller spinout will use the series C proceeds to advance two cancer drug candidates through early-stage clinical trials.
OmniSci maps out $55m series C
OmniSci, formerly known as MapD and based on research at MIT, has added $55m to its coffers thanks to investors including Nvidia and Verizon, bringing its total funding to $92m.
Fusion pipes in $8m series C
University of Michigan's manufacturing coolant spinout Fusion Coolant Systems has been backed by the institution's Mints fund, taking its total to $9.9m.
Bellen sells investors on series C round
The nine-figure renminbi sum follows a series A round of undisclosed size two years ago that was backed by THG Ventures.
Investors go with gut in $83m UBiome round
Stanford-StartX Fund-backed microbial diagnostics and wellness product developer UBiome has raised $83m in series C funding.
Atreca carries on funding streak

test reg